Coremine Vitae is a patient-centered biomedical company. Our wish is to give everyone the opportunity to receive personalized medicine by producing evidence-based information about the best treatment options based on the patient's profile and biomarkers.
Coremine Vitae has a broad scientific background with "state of the art" knowledge in molecular biology, biomedicine, oncology and medicine. Most of the people in our analysis team have a PhD and extensive experience from research and clinical patient care.
We have participated and are participating in a number of research projects in collaboration with leading medical environments in Norway and Europe.
The Coremine Vitae team collaborates with PubGene AS in the research project "Coremine Vitae - to identify personalized treatment options for cancer patients" where Haukeland University Hospital and Sykehuset Innlandet are partners. The research project has support from the Research Council of Norway and includes both the development of analysis tools and the implementation of Coremine Vitae analyzes for patients in order to generate information about relevant treatments.
We work closely with PubGene AS and Vitae Evidence AS, which provide complementary knowledge in bioinformatics and tool support for our medical analysts.